Bvf Partners L P Xoma Corp (XOMA) insider trading activity

XOMA Quotes by TradingView

Bvf Partners L P is Director of XOMA Corp. Currently has a direct ownership of 1.62 Million shares of XOMA, which is worth approximately $39.8 Million. The most recent transaction as insider was on Apr 15, 2020, when has been sold 1,252,772 shares (Common Stock, $0.0075 par value per share) at a price of $13.0 per share, resulting in proceeds of $16,286,036. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.62M
0% 3M change
0% 12M change
Total Value Held $39.8 Million

BVF PARTNERS L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 15 2020
BUY
Conversion of derivative security
$16,286,036 $13.0 p/Share
1,252,772 Added 42.43%
1,700,127 Common Stock, $0.0075 ...
Mar 25 2020
BUY
Open market or private purchase
$142,141 $17.2 p/Share
8,264 Added 0.64%
1,278,656 Common Stock, $0.0075 ...
Mar 18 2020
BUY
Open market or private purchase
$64,454 $14.52 p/Share
4,439 Added 0.35%
1,270,392 Common Stock, $0.0075 ...
Mar 17 2020
BUY
Open market or private purchase
$127,617 $15.73 p/Share
8,113 Added 0.64%
1,265,953 Common Stock, $0.0075 ...
Mar 16 2020
BUY
Open market or private purchase
$159,880 $15.73 p/Share
10,164 Added 0.8%
1,257,840 Common Stock, $0.0075 ...
Mar 13 2020
BUY
Open market or private purchase
$1,834,000 $18.34 p/Share
100,000 Added 7.42%
1,247,676 Common Stock, $0.0075 ...
Dec 19 2019
BUY
Open market or private purchase
$8,210,290 $22.0 p/Share
373,195 Added 25.28%
1,103,314 Common Stock, $0.0075 ...
Dec 18 2019
BUY
Exercise of in-the-money or at-the-money derivatives securities
$10,389,896 $22.0 p/Share
472,268 Added 74.75%
159,537 Common Stock, $0.0075 ...
May 14 2019
BUY
Open market or private purchase
$203,648 $14.74 p/Share
13,816 Added 1.82%
746,454 Common Stock, $0.0075 ...
May 13 2019
BUY
Open market or private purchase
$54,525 $14.36 p/Share
3,797 Added 0.52%
732,638 Common Stock, $0.0075 ...
May 10 2019
BUY
Open market or private purchase
$150,071 $14.57 p/Share
10,300 Added 1.39%
728,841 Common Stock, $0.0075 ...
Dec 17 2018
BUY
Open market or private purchase
$354,750 $14.19 p/Share
25,000 Added 3.36%
718,541 Common Stock, $0.0075 ...
Dec 13 2018
BUY
Open market or private purchase
$349,486 $14.41 p/Share
24,253 Added 3.38%
693,541 Common Stock, $0.0075 ...
Dec 12 2018
BUY
Open market or private purchase
$41,448 $14.75 p/Share
2,810 Added 0.42%
669,288 Common Stock, $0.0075 ...
Dec 11 2018
BUY
Open market or private purchase
$136,300 $14.5 p/Share
9,400 Added 1.39%
666,478 Common Stock, $0.0075 ...
Dec 10 2018
BUY
Open market or private purchase
$262,898 $14.54 p/Share
18,081 Added 2.68%
657,078 Common Stock, $0.0075 ...
Dec 07 2018
BUY
Open market or private purchase
$472,862 $14.77 p/Share
32,015 Added 4.77%
638,997 Common Stock, $0.0075 ...
Dec 06 2018
BUY
Open market or private purchase
$161,720 $14.8 p/Share
10,927 Added 1.77%
606,982 Common Stock, $0.0075 ...
Dec 04 2018
BUY
Open market or private purchase
$62,523 $14.99 p/Share
4,171 Added 0.69%
596,055 Common Stock, $0.0075 ...
Dec 03 2018
BUY
Open market or private purchase
$12,009 $14.9 p/Share
806 Added 0.14%
591,884 Common Stock, $0.0075 ...
Nov 30 2018
BUY
Open market or private purchase
$71,622 $14.85 p/Share
4,823 Added 0.81%
591,078 Common Stock, $0.0075 ...
Nov 29 2018
BUY
Open market or private purchase
$149,539 $14.93 p/Share
10,016 Added 1.68%
586,255 Common Stock, $0.0075 ...
Nov 28 2018
BUY
Open market or private purchase
$125,232 $15.11 p/Share
8,288 Added 1.42%
576,239 Common Stock, $0.0075 ...
Nov 27 2018
BUY
Open market or private purchase
$173,675 $15.24 p/Share
11,396 Added 1.97%
567,951 Common Stock, $0.0075 ...
Nov 21 2018
BUY
Open market or private purchase
$375,000 $15.0 p/Share
25,000 Added 4.3%
556,555 Common Stock, $0.0075 ...

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CNCE
CONCERT PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CTIC
CTI BIOPHARMA CORP Healthcare
Director
XENE
Xenon Pharmaceuticals Inc. Healthcare
> 10% Shareholder
ARQL
ARQULE INC
> 10% Shareholder
SNDX
Syndax Pharmaceuticals Inc Healthcare
> 10% Shareholder
IMDZ
IMMUNE DESIGN CORP.
> 10% Shareholder
PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
GLYC
GLYCOMIMETICS INC Healthcare
> 10% Shareholder
FPRX
FIVE PRIME THERAPEUTICS, INC.
CALA
Calithera Biosciences, Inc. Healthcare
> 10% Shareholder
CYTK
CYTOKINETICS INC Healthcare
MRUS
Merus N.V. Healthcare
> 10% Shareholder
IDYA
IDEAYA Biosciences, Inc. Healthcare
PRNB
Principia Biopharma Inc.
> 10% Shareholder
KYMR
Kymera Therapeutics, Inc. Healthcare
Director
OLMA
Olema Pharmaceuticals, Inc. Healthcare
Director
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
RAIN
Rain Therapeutics Inc. Healthcare
Director
RPTX
Repare Therapeutics Inc. Healthcare
> 10% Shareholder
CGEM
Cullinan Oncology, Inc. Healthcare
> 10% Shareholder
THRD
Third Harmonic Bio, Inc. Healthcare
> 10% Shareholder
GPCR
Structure Therapeutics Inc.
> 10% Shareholder
MLTX
MoonLake Immunotherapeutics Healthcare
Director
PNT
POINT Biopharma Global Inc. Healthcare
BPL

Bvf Partners L P

Director
San Francisco, CA

Track Institutional and Insider Activities on XOMA

Follow XOMA Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XOMA shares.

Notify only if

Insider Trading

Get notified when an Xoma Corp insider buys or sells XOMA shares.

Notify only if

News

Receive news related to XOMA Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XOMA